Latest DTU publications
-
Proteomic pathways across the ejection fraction spectrum in patients with heart failure and diabetes mellitus: an EXSCEL trial substudy
Journal article
Peters AE. et al, (2025), Scientific Reports, 15
-
International Variation in Case Fatality After Major Coronary or Cerebrovascular Events in Individuals With Type 2 Diabetes: Evidence From ADVANCE, TECOS, and EXSCEL
Journal article
Clarke PM. et al, (2025), Diabetes Care
-
Validation of a treatment selection algorithm for optimal choice of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups
Preprint
Güdemann LM. et al, (2025)
-
Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes: an EXSCEL post hoc analysis
Journal article
Coleman RL. et al, (2025), Cardiovascular Diabetology, 24
-
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Journal article
Gillessen S. et al, (2025), Lancet Oncol
-
Utilization of Proteomic Measures for Early Detection of Drug Benefits and Adverse Effects.
Journal article
Chadwick J. et al, (2025), J Clin Pharmacol
-
Missing Pieces of the Puzzle to Address Market Failures for Antibiotics: Delinked Payment Systems and Insurance Value.
Journal article
Hawkins N. et al, (2025), Pharmacoecon Open
-
A systematic review of in vivo brain insulin resistance biomarkers in humans
Journal article
Reid G. et al, (2025), Biomarkers in Neuropsychiatry, 12
-
Long-term outcomes following alternative second-line oral glucose-lowering treatments: Results from the real-world progression in type 2 diabetes mellitus United Kingdom (RAPIDS-UK) model.
Journal article
Carroll OU. et al, (2025), Diabetes, obesity & metabolism
-
Comparative effectiveness of alternative second-line oral glucose-lowering therapies for type 2 diabetes: a precision medicine approach applied to routine data.
Journal article
O'Neill S. et al, (2025), Diabetologia
-
Glucocorticoid-induced hyperglycaemia in hospitalised adults: A matched cohort study (2013-2023).
Journal article
Golubic R. et al, (2025), Diabetes Obes Metab
-
Frailty in randomized controlled trials of glucose-lowering therapies for type 2 diabetes: An individual participant data meta-analysis of frailty prevalence, treatment efficacy, and adverse events.
Journal article
Wightman H. et al, (2025), PLoS Med, 22
-
Response to Comments on Maddaloni et al. Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL. Diabetes Care 2025;48:235-242.
Journal article
Maddaloni E. et al, (2025), Diabetes Care, 48, e61 - e62
-
Risk factors for bone fractures in type 2 diabetes and the impact of once-weekly exenatide: Insights from an EXSCEL post-hoc analysis.
Journal article
Maddaloni E. et al, (2025), Diabetes Res Clin Pract
-
Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes: A Network Meta-Analysis.
Journal article
Hanlon P. et al, (2025), JAMA, 333, 1062 - 1073
-
Effects of intensive blood pressure treatment on orthostatic hypertension: individual level meta-analysis.
Journal article
Juraschek SP. et al, (2025), BMJ, 388
-
Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities
Journal article
Loesch DP. et al, (2025), Nature Communications, 16
-
Glucocorticoid treatment and new-onset hyperglycaemia and diabetes in people living with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
Journal article
Golubic R. et al, (2025), Diabet Med, 42
-
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
Journal article
De Giorgi R. et al, (2025), Nature Mental Health, 3, 354 - 373
-
Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes.
Journal article
Sammons E. et al, (2025), BMJ Open, 15
About DTU
About DTU
Our People
Our Studies
CONTACT US
Phone: +44 (0)1865 857240
Email: dtu@dtu.ox.ac.uk